These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 19361606)

  • 1. Features of cardiac allograft coronary endothelial dysfunction.
    Raichlin E; Kushwaha SS; Lennon RJ; Frantz RP; Edwards BS; Prasad A; Rihal CS; Lerman A
    Am J Cardiol; 2009 Apr; 103(8):1154-8. PubMed ID: 19361606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology.
    Drexler H; Fischell TA; Pinto FJ; Chenzbraun A; Botas J; Cooke JP; Alderman EL
    Circulation; 1994 Apr; 89(4):1615-23. PubMed ID: 8149529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation.
    Hollenberg SM; Tamburro P; Klein LW; Burns D; Easington C; Costanzo MR; Parrillo JE; Johnson MR
    J Heart Lung Transplant; 1998 May; 17(5):487-94. PubMed ID: 9628567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients.
    Schubert S; Abdul-Khaliq H; Wellnhofer E; Hiemann NE; Ewert P; Lehmkuhl HB; Meyer R; Miera O; Peters B; Hetzer R; Berger F
    J Heart Lung Transplant; 2008 May; 27(5):514-21. PubMed ID: 18442717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E.
    Behrendt D; Beltrame J; Hikiti H; Wainstein M; Kinlay S; Selwyn AP; Ganz P; Fang JC
    J Heart Lung Transplant; 2006 Apr; 25(4):426-33. PubMed ID: 16563973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients.
    Raichlin E; Prasad A; Kremers WK; Edwards BS; Rihal CS; Lerman A; Kushwaha SS
    Eur Heart J; 2009 Jun; 30(11):1356-63. PubMed ID: 19383734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allograft vasculopathy in the early phase of orthotopic heart transplantation: angiography, intravascular ultrasound and functional in vivo findings].
    Kerber S; Rahmel A; Karbenn U; Heinemann-Vechtel O; Fechtrup C; Lamp B; Block M; Budde T; Hoffmeier A; Weyand M
    Z Kardiol; 1994 Mar; 83(3):215-24. PubMed ID: 8178545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
    Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
    Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasomotor response to phenylephrine in heart transplant patients.
    Aptecar E; Le Corvoisier P; Teiger E; Dupouy P; Vermes E; Sediame S; Hittinger L; Loisance D; Dubois-Rande JL; Montagne O
    J Heart Lung Transplant; 2006 Aug; 25(8):912-20. PubMed ID: 16890111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens.
    Weis M; Wildhirt SM; Schulze C; Pehlivanli S; Rieder G; Wolf WP; Wilbert-Lampen U; Meiser BM; Enders G; von Scheidt W
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):776-84. PubMed ID: 11117379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary dilatation after heart transplantation.
    Nickel T; Bigdeli A; von Ziegler F; Wilbert-Lampen U; Lackermair K; Horster S; Hoster E; Uberfuhr P; von Scheidt W; Weis M; Kaczmarek I
    Transplantation; 2011 Sep; 92(6):697-702. PubMed ID: 21799467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular resistance and endothelial function in cyclosporine-treated lung transplant recipients.
    Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
    Transpl Int; 2006 Dec; 19(12):974-81. PubMed ID: 17081226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
    Moien-Afshari F; Choy JC; McManus BM; Laher I
    J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients.
    Wu YW; Chen YH; Wang SS; Jui HY; Yen RF; Tzen KY; Chen MF; Lee CM
    J Nucl Med; 2010 Jun; 51(6):906-12. PubMed ID: 20484427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased arterial stiffness in cyclosporine-treated lung transplant recipients early after transplantation.
    Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
    Clin Transplant; 2004 Aug; 18(4):473-9. PubMed ID: 15233828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
    Weis M; Kledal TN; Lin KY; Panchal SN; Gao SZ; Valantine HA; Mocarski ES; Cooke JP
    Circulation; 2004 Feb; 109(4):500-5. PubMed ID: 14732750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients.
    Weis M; Wildhirt SM; Schulze C; Pehlivanli S; Fraunberger P; Meiser BM; von Scheidt W
    Transplantation; 1999 Nov; 68(9):1263-7. PubMed ID: 10573061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis.
    Larose E; Behrendt D; Kinlay S; Selwyn AP; Ganz P; Fang JC
    Circ Heart Fail; 2009 Sep; 2(5):409-16. PubMed ID: 19808370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway.
    Weis M; Cooke JP
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):567-75. PubMed ID: 12649081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.